CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF...Umbrella Development Services Agreement • October 26th, 2018 • Kaleido Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
The following services are out of scope for this Master Agreement and would require additional terms to be agreed by the parties:
